<p>ICU Medical（纳斯达克代码：ICUI - 获取免费报告）在周四更新了其 2026 财年的收益指引。公司提供的每股收益指引为 7.750-8.450，而市场共识的每股收益预期为 7.740。公司发布的收入指引为-。</p>
<h2>分析师升级与降级</h2>
<p>多家股票研究分析师对该股票发布了报告。Piper Sandler 将 ICU Medical 的目标股价从 178.00 美元下调至 163.00 美元，并在 4 月 17 日的研究报告中给予该股票 “超配” 评级。KeyCorp 将 ICU Medical 的目标股价从 180.00 美元下调至 164.00 美元，并在 4 月 27 日的研究报告中给予该股票 “超配” 评级。Wall Street Zen 在 4 月 18 日的研究报告中将 ICU Medical 的评级从 “买入” 下调至 “持有”。最后，Weiss Ratings 在 1 月 22 日的研究报告中重申了对 ICU Medical 的 “卖出（d-）” 评级。一位分析师给予该股票 “强烈买入” 评级，两位给予 “买入” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，平均目标价格为 169.00 美元。</p>
<p><strong>查看我们关于 ICU Medical 的最新股票报告</strong></p>
<h2>ICU Medical 价格表现</h2>
<p>周四，ICUI 股票上涨 3.48 美元，达到 123.07 美元。该公司交易了 351,997 股，较其平均交易量 275,739 股有所增加。该公司的 50 日移动平均线为 129.52 美元，200 日移动平均线为 138.31 美元。公司市值为 30.8 亿美元，市盈率为 6,156.58，市盈率/增长比率为 1.69，贝塔值为 0.74。ICU Medical 的 12 个月低点为 107.00 美元，12 个月高点为 160.29 美元。公司的债务与股本比率为 0.60，流动比率为 2.39，速动比率为 1.15。</p>
<p>ICU Medical（纳斯达克代码：ICUI - 获取免费报告）最近在 5 月 7 日发布了季度收益数据。这家医疗器械供应商报告的每股收益（EPS）为 1.97 美元，超出分析师共识预期的 1.78 美元，超出幅度为 0.19 美元。该季度的收入为 5.2577 亿美元，而分析师预期为 5.2065 亿美元。ICU Medical 的净利润率为 0.03%，股本回报率为 7.33%。ICU Medical 已将其 2026 财年的指引设定为每股收益 7.750-8.450。整体来看，股票分析师预测 ICU Medical 在当前财年将发布 6.31 美元的每股收益。</p>
<h2>ICU Medical 的机构交易</h2>
<p>几家对冲基金最近调整了对 ICUI 的持股。Millennium Management LLC 在第三季度将其在 ICU Medical 的持股增加了 173.4%。Millennium Management LLC 现在拥有 1,089,017 股该医疗器械供应商的股票，价值 1.30638 亿美元，此前在该期间又购买了 690,694 股。瑞银集团（UBS Group AG）在第三季度将其在 ICU Medical 的持股增加了 239.8%。瑞银集团现在拥有 386,555 股该医疗器械供应商的股票，价值 4,637.1 万美元，此前在上个季度又购买了 272,782 股。Ameriprise Financial Inc.在第三季度将其在 ICU Medical 的持股增加了 34.0%。Ameriprise Financial Inc.现在拥有 803,542 股该医疗器械供应商的股票，价值 9,639.3 万美元，此前在上个季度又购买了 203,746 股。Dimensional Fund Advisors LP 在第三季度将其在 ICU Medical 的持股增加了 16.9%。Dimensional Fund Advisors LP 现在拥有 872,993 股该医疗器械供应商的股票，价值 1.04718 亿美元，此前在上个季度又购买了 126,072 股。最后，Janus Henderson Group PLC 在第四季度将其在 ICU Medical 的持股增加了 4.2%。Janus Henderson Group PLC 现在拥有 2,576,756 股该医疗器械供应商的股票，价值 3.67625 亿美元，此前在该期间又购买了 103,220 股。机构投资者持有该公司 96.10% 的股份。</p>
<h2>ICU Medical 公司简介</h2>
<p>（获取免费报告）</p>
<p>ICU Medical, Inc 及其子公司开发、制造和销售用于输液治疗、血管通路和生命监护应用的医疗设备。其输液治疗产品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的无针产品；Neutron 导管通畅设备；ChemoClave 和 ChemoLock 封闭系统转移设备，用于限制有害药物或蒸汽浓度的逸出，阻止环境污染物进入系统，并消除针刺伤害的风险；Tego 无针连接器；Deltec GRIPPER 非穿刺针用于门静脉通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，而非 ICU Medical</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 ICU Medical 吗？</h2>
<p>在你考虑 ICU Medical 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 ICU Medical 并不在名单上。</p>
<p>虽然 ICU Medical 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

ICU医疗

<p>ICU Medical (NASDAQ:ICUI) 更新了其 2026 财年的收益指引，预计每股收益在 7.750 到 8.450 之间，略高于市场共识预期的 7.740。该公司的股票表现上涨了 3.48 美元，达到 123.07 美元，市值为 30.8 亿美元。分析师对该股票的评级不一，市场共识评级为 “适度买入”，平均目标价为 169.00 美元。机构投资者持有该公司 96.10% 的股份，反映出机构对 ICU Medical 的强烈兴趣</p>

<p>ICU Medical (NASDAQ:ICUI - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 7.750-8.450 for the period, compared to the consensus earnings per share estimate of 7.740. The company issued revenue guidance of -.</p>
<div class="lb-trans"><p>ICU Medical（纳斯达克代码：ICUI - 获取免费报告）在周四更新了其 2026 财年的收益指引。公司提供的每股收益指引为 7.750-8.450，而市场共识的每股收益预期为 7.740。公司发布的收入指引为-。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级与降级</h2>
</div><p>A number of equities research analysts have issued reports on the stock. Piper Sandler reduced their price objective on shares of ICU Medical from $178.00 to $163.00 and set an &#34;overweight&#34; rating on the stock in a research note on Friday, April 17th. KeyCorp reduced their price objective on shares of ICU Medical from $180.00 to $164.00 and set an &#34;overweight&#34; rating on the stock in a research note on Monday, April 27th. Wall Street Zen downgraded shares of ICU Medical from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, April 18th. Finally, Weiss Ratings reiterated a &#34;sell (d-)&#34; rating on shares of ICU Medical in a research note on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $169.00.</p>
<div class="lb-trans"><p>多家股票研究分析师对该股票发布了报告。Piper Sandler 将 ICU Medical 的目标股价从 178.00 美元下调至 163.00 美元，并在 4 月 17 日的研究报告中给予该股票 “超配” 评级。KeyCorp 将 ICU Medical 的目标股价从 180.00 美元下调至 164.00 美元，并在 4 月 27 日的研究报告中给予该股票 “超配” 评级。Wall Street Zen 在 4 月 18 日的研究报告中将 ICU Medical 的评级从 “买入” 下调至 “持有”。最后，Weiss Ratings 在 1 月 22 日的研究报告中重申了对 ICU Medical 的 “卖出（d-）” 评级。一位分析师给予该股票 “强烈买入” 评级，两位给予 “买入” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，平均目标价格为 169.00 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on ICU Medical</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 ICU Medical 的最新股票报告</strong></p>
</div><h2>ICU Medical Price Performance</h2>
<div class="lb-trans"><h2>ICU Medical 价格表现</h2>
</div><p>ICUI stock traded up $3.48 during trading on Thursday, reaching $123.07. 351,997 shares of the company were exchanged, compared to its average volume of 275,739. The company has a 50-day moving average of $129.52 and a two-hundred day moving average of $138.31. The company has a market capitalization of $3.08 billion, a price-to-earnings ratio of 6,156.58, a P/E/G ratio of 1.69 and a beta of 0.74. ICU Medical has a twelve month low of $107.00 and a twelve month high of $160.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.39 and a quick ratio of 1.15.</p>
<div class="lb-trans"><p>周四，ICUI 股票上涨 3.48 美元，达到 123.07 美元。该公司交易了 351,997 股，较其平均交易量 275,739 股有所增加。该公司的 50 日移动平均线为 129.52 美元，200 日移动平均线为 138.31 美元。公司市值为 30.8 亿美元，市盈率为 6,156.58，市盈率/增长比率为 1.69，贝塔值为 0.74。ICU Medical 的 12 个月低点为 107.00 美元，12 个月高点为 160.29 美元。公司的债务与股本比率为 0.60，流动比率为 2.39，速动比率为 1.15。</p>
</div><p>ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.78 by $0.19. The business had revenue of $525.77 million during the quarter, compared to analyst estimates of $520.65 million. ICU Medical had a net margin of 0.03% and a return on equity of 7.33%. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. As a group, equities analysts predict that ICU Medical will post 6.31 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>ICU Medical（纳斯达克代码：ICUI - 获取免费报告）最近在 5 月 7 日发布了季度收益数据。这家医疗器械供应商报告的每股收益（EPS）为 1.97 美元，超出分析师共识预期的 1.78 美元，超出幅度为 0.19 美元。该季度的收入为 5.2577 亿美元，而分析师预期为 5.2065 亿美元。ICU Medical 的净利润率为 0.03%，股本回报率为 7.33%。ICU Medical 已将其 2026 财年的指引设定为每股收益 7.750-8.450。整体来看，股票分析师预测 ICU Medical 在当前财年将发布 6.31 美元的每股收益。</p>
</div><h2>Institutional Trading of ICU Medical</h2>
<div class="lb-trans"><h2>ICU Medical 的机构交易</h2>
</div><p>Several hedge funds have recently modified their holdings of ICUI. Millennium Management LLC increased its position in shares of ICU Medical by 173.4% during the third quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier's stock valued at $130,638,000 after buying an additional 690,694 shares during the period. UBS Group AG boosted its stake in ICU Medical by 239.8% in the third quarter. UBS Group AG now owns 386,555 shares of the medical instruments supplier's stock worth $46,371,000 after buying an additional 272,782 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in ICU Medical by 34.0% in the third quarter. Ameriprise Financial Inc. now owns 803,542 shares of the medical instruments supplier's stock worth $96,393,000 after buying an additional 203,746 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in ICU Medical by 16.9% in the third quarter. Dimensional Fund Advisors LP now owns 872,993 shares of the medical instruments supplier's stock worth $104,718,000 after buying an additional 126,072 shares in the last quarter. Finally, Janus Henderson Group PLC boosted its stake in shares of ICU Medical by 4.2% during the fourth quarter. Janus Henderson Group PLC now owns 2,576,756 shares of the medical instruments supplier's stock valued at $367,625,000 after purchasing an additional 103,220 shares during the period. Institutional investors own 96.10% of the company's stock.</p>
<div class="lb-trans"><p>几家对冲基金最近调整了对 ICUI 的持股。Millennium Management LLC 在第三季度将其在 ICU Medical 的持股增加了 173.4%。Millennium Management LLC 现在拥有 1,089,017 股该医疗器械供应商的股票，价值 1.30638 亿美元，此前在该期间又购买了 690,694 股。瑞银集团（UBS Group AG）在第三季度将其在 ICU Medical 的持股增加了 239.8%。瑞银集团现在拥有 386,555 股该医疗器械供应商的股票，价值 4,637.1 万美元，此前在上个季度又购买了 272,782 股。Ameriprise Financial Inc.在第三季度将其在 ICU Medical 的持股增加了 34.0%。Ameriprise Financial Inc.现在拥有 803,542 股该医疗器械供应商的股票，价值 9,639.3 万美元，此前在上个季度又购买了 203,746 股。Dimensional Fund Advisors LP 在第三季度将其在 ICU Medical 的持股增加了 16.9%。Dimensional Fund Advisors LP 现在拥有 872,993 股该医疗器械供应商的股票，价值 1.04718 亿美元，此前在上个季度又购买了 126,072 股。最后，Janus Henderson Group PLC 在第四季度将其在 ICU Medical 的持股增加了 4.2%。Janus Henderson Group PLC 现在拥有 2,576,756 股该医疗器械供应商的股票，价值 3.67625 亿美元，此前在该期间又购买了 103,220 股。机构投资者持有该公司 96.10% 的股份。</p>
</div><h2>ICU Medical Company Profile</h2>
<div class="lb-trans"><h2>ICU Medical 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.</p>
<div class="lb-trans"><p>ICU Medical, Inc 及其子公司开发、制造和销售用于输液治疗、血管通路和生命监护应用的医疗设备。其输液治疗产品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的无针产品；Neutron 导管通畅设备；ChemoClave 和 ChemoLock 封闭系统转移设备，用于限制有害药物或蒸汽浓度的逸出，阻止环境污染物进入系统，并消除针刺伤害的风险；Tego 无针连接器；Deltec GRIPPER 非穿刺针用于门静脉通路；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than ICU Medical</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而非 ICU Medical</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in ICU Medical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 ICU Medical 吗？</h2>
</div><p>Before you consider ICU Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 ICU Medical 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 ICU Medical 并不在名单上。</p>
</div><p>While ICU Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 ICU Medical 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

ICU Medical（NASDAQ:ICUI）更新 2026 财年盈利指引